Skip to main content

IPI Legacy Liquidation Co

IMPLDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001445499

IPI Legacy Liquidation Co was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Apr 9, 2024; 32 institutions reported holding it in 13F filings for Q3 2023, worth $7.35M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by IPI Legacy Liquidation Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for IPI Legacy Liquidation Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for IPI Legacy Liquidation Co
NameTitleLast reported holdingLast filingFilings, past year
Nelson Timothy SDirector0Apr 9, 20240
Wilfong Diane E.Director–Apr 9, 20240
Allison David D.Director–Apr 9, 20240
Vivo Capital Fund VIII, L.P.10% Owner280,294IndirectDec 19, 20230
Vivo Capital VIII, LLC10% Owner280,294IndirectDec 19, 20230
Vivo Capital Surplus Fund VIII, L.P.10% Owner280,294IndirectDec 19, 20230
BROOKFIELD Corp10% Owner–Dec 4, 20230
BAM Partners Trust10% Owner–Dec 4, 20230
Brookfield Asset Management ULC10% Owner–Dec 4, 20230
Brookfield Oaktree Holdings, LLC10% Owner–Dec 4, 20230
Oaktree Capital Holdings, LLC10% Owner–Dec 4, 20230
Oaktree Diversified Income Fund Inc.10% Owner–Dec 4, 20230
Oaktree AZ Strategic Lending Fund, L.P.10% Owner–Dec 4, 20230
Oaktree Loan Acquisition Fund, L.P.10% Owner–Dec 4, 20230
Oaktree LSL Fund Delaware Holdings EURRC, L.P.10% Owner–Dec 4, 20230
Oaktree PRE Life Sciences Fund, L.P.10% Owner–Dec 4, 20230
Oaktree GCP Fund Delaware Holdings, L.P.10% Owner–Dec 4, 20230
Oaktree LSL Fund Holdings EURRC S.a.r.l.10% Owner–Dec 4, 20230
Oaktree Specialty Lending Corp10% Owner–Dec 4, 20230
Oaktree-Forrest Multi-Strategy,LLC10% Owner–Dec 4, 20230
Oaktree-TCDRS Strategic Credit, LLC10% Owner–Dec 4, 20230
Oaktree-TBMR Strategic Credit Fund G, LLC10% Owner–Dec 4, 20230
Oaktree-TBMR Strategic Credit Fund F, LLC10% Owner–Dec 4, 20230
Oaktree-TBMR Strategic Credit Fund C, LLC10% Owner–Dec 4, 20230
Oaktree-TSE 16 Strategic Credit, LLC10% Owner–Dec 4, 20230
Oaktree Gilead Investment Fund AIF (Delaware), L.P.10% Owner–Dec 4, 20230
Oaktree Strategic Credit Fund10% Owner–Dec 4, 20230
INPRS Strategic Credit Holdings, LLC10% Owner–Dec 4, 20230
Shah MahendraDirector–Jun 20, 20230
Cline Darren SDirector–Jun 20, 20230
Kalb Michael WayneCFO–May 12, 20230
Adams AdrianCOB, CEO and President20,000Feb 16, 20230
Leaman John HaroldChief Fin. & Business Officer6,944Feb 16, 20230
Paolillo LeonardChief Commercial Officer–Feb 16, 20230
Hoekman JohnChief Scientific Officer128,221Feb 16, 20230
Parker H StewartDirector–Jun 17, 20220
Shrewsbury Stephen BChief Medical Officer97,990Mar 30, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 19, 2023 (view filing)6:00 PM ETDec 15-194 daysVivo Capital Fund VIII, L.P. and 2 others10% OwnerSSale−575.0K$0.1289−$74.1K−67.2%280.3K after6 lots
Nov 22, 2021 (view filing)Nov 193 daysNelson Timothy SDirectorPPurchase+10.0K$10.76+$107.6KNew position10.0K after
Aug 19, 2021 (view filing)Aug 181 dayAdams AdrianCOB, CEO and PresidentPPurchase+20.0K$13.99+$279.9KNew position20.0K after3 lots